Our data demonstrate that inhibition of NKCC1 protein in glioma cells with BMT or STS66 suppresses AKT and ERK signaling pathways in response to TMZ stress but has no effects on mTORC1 signaling. The gene discussed is SLC12A2; the disease is central nervous system cancer.